Does HIV test result influence methadone maintenance treatment retention?

Journal of Substance Abuse

Volumn 8, Issue 2, 1996, Pages 263-269

  Wimbush, Julian ^a   Amicarelli, Anthony ^b   Stein, Michael D ^c,d  

^a BROWN UNIVERSITY   (United States)

^b CODAC II Methadone Program ^*  (United States)

^c BROWN UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0029785942     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(96)90304-1     Document Type: Article

References (14)

1. Centers for Disease Control. (1986). Additional recommendations to reduce sexual and drug-related transmission of HTL VII/LAV. Morbidity and Mortality Weekly Review; 35, 152-155.
2. Centers for Disease Control and Prevention Update. (1995),. Acquired immunodeficiency syndrome - United States 1994. Morbidity and Mortality Weekly Review, 44, 664-671.
3. Condelli, W.S. (1993). Strategies for increasing retention in methadone programs. Journal of Psychoactive Drugs, 25, 143-145.
4. Curtis, J.L., Crummey, F.C., Baker, S.N., Foster, R.E., Khanyiele, C.S., & Wilkins, R. (1989). HIV screening and counseling for intravenous drug abuse patients. Journal of the American Medical Association, 261, 258-262.
5. Farley, T.A., Cartter, M.L., Wassell, J.T., & Hadler, J.L. (1991). Predictors of outcome in methadone programs; Effect of HIV counseling and testing. AIDS, 6, 15-21.
6. Fisher, D.G, & Anglin, M.D. (1987). Survival analysis in drug program evaluation. Part 1. Overall Program Effectiveness. International Journal of Addiction, 22, 115-134.
7. Hanbury, R., Sturiano, V., Cohen, M., Stimmel, B., & Aguillaume, C. (1986). Cocaine use in persons on methadone maintenance. Advances of Alcohol and Substance Abuse, 6, 97-106.
8. Magura, S., Grossman, J.I.., Lipton, D.S., Amann, K.R., Roger, J., & Gehan, K. (1989). Correlates of participation in AIDS education and HIV antibody testing by methadone patients. Public Health Reports, 104, 231-240.
9. McLellan, A.T., Luborsky, L., & O'Brien, C.P. (1980). An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26-33.
10. Moulton, J.M., Stempel, R.R., Bacchetti, P., Temoshok, L., & Moss, A.R. (1991). Results of a one year longitudinal study of HIV antibody test notification from the San Francisco General Hospital cohort. Journal of AIDS, 4, 787-794.
11. O'Connor, P.G., Selwyn, P.A., & Schottenfeld, R.S. (1994). Medical care for injection drug users with human immunodeficiency virus infection. New England Journal of Medicine, 331, 456-459.
12. Perry, S., Jacobsberg, L., & Fishman, B. (1990). Suicidal ideation and HIV testing. Journal of the American Medical Association, 263, 679-682.
13. Rounsaville, B.J., Tiemey, T., Crits-Cristoph, K., Weissman, M., & Kleber, H.D. (1982). Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts' problems. Comprehensive Psychiatry, 23, 462-478.
14. Weddington, W.W., & Brown, B.S. (1988). Acceptance of HIV-antibody testing by persons seeking outpatient treatment for cocaine abuse. Journal of Substance Abuse Treatment, 5, 145-149.